Dallas Matthew D

Chief Financial Officer at CoLucid Pharmaceuticals, Inc.; VP, Finance at AVEO PHARMACEUTICALS INC

Sold, on record
$108k
Dollars the filings state
Form 4 sales
4
Latest Jan 3, 2017
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale AVEO PHARMACEUTICALS INCPlan not stated
    Jan 7, 2015 2015

    Sold 519 shares at $0.80 ($415)

    Dallas Matthew D, VP, Finance

    Sold 2.9% of holdings ($14k position)17,581 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale AVEO PHARMACEUTICALS INCPlan not stated
    Jan 16, 2015 +9 days

    Sold 3,075 shares at $0.82 ($3k)

    Dallas Matthew D, VP, Finance

    Sold 17.5% of holdings ($14k position)14,506 shares leftFiling

  3. 3 Form 4 sale CoLucid Pharmaceuticals, Inc.Plan not stated
    Dec 1, 2016 +685 days

    Sold 1,473 shares at $35.17 ($52k)

    Dallas Matthew D, Chief Financial Officer

    Sold 3.4% of holdings ($1.5M position)41,601 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale CoLucid Pharmaceuticals, Inc.Plan not stated
    Jan 3, 2017 +33 days

    Sold 1,473 shares at $36.25 ($53k)

    Dallas Matthew D, Chief Financial Officer

    Sold 3.5% of holdings ($1.5M position)40,128 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Dallas Matthew D
Source
Jan 3, 2017Jan 4, 2017CoLucid Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale1,473$53k3.5%Plan not statedSEC
Dec 1, 2016Dec 1, 2016CoLucid Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale1,473$52k3.4%Plan not statedSEC
Jan 16, 2015Jan 20, 2015AVEO PHARMACEUTICALS INCVP, FinanceForm 4 sale3,075$3k17.5%Plan not statedSEC
Jan 7, 2015Jan 8, 2015AVEO PHARMACEUTICALS INCVP, FinanceForm 4 sale519$4152.9%Plan not statedSEC